Bexlutry Injection
Product Images NDC 69945-177

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bexlutry (NDC 69945-177). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Curium Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Bexlutry Vial Label)

Bexlutry (lutetium Lu 177 dotatate injection) 10 mCi/mL for intravenous infusion. Single-dose vial label displays activity at calibration and infusion times, lot number, expiration date, volume, and handling instructions. Manufactured by Curium US LLC in Noblesville, Indiana. Includes storage recommendations and radiation hazard caution.*

FDA Label Image

Image Description (Lutetium Lu 177 Dotatate Injection 01)

Chemical structure diagram of the active ingredient lutetium oxodotreotide Lu-177, showing its molecular configuration with labeled atoms and bonds.*

FDA Label Image

Image Description (Lutetium Lu 177 Dotatate Injection 021)

This Kaplan-Meier survival curve graph depicts progression-free survival percentages over time in months for two treatments: Lutetium Lu 177 Dotatate Injection and Long-Acting Octreotide. The chart compares their effectiveness, showing higher survival percentages over time for the Lutetium Lu 177 Dotatate Injection group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.